Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the ten ratings firms that are currently covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $47.94.
Several analysts have recently commented on ACHC shares. Guggenheim started coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price target on the stock. Mizuho decreased their price objective on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Stephens upgraded Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Finally, KeyCorp decreased their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th.
Get Our Latest Analysis on Acadia Healthcare
Institutional Trading of Acadia Healthcare
Hedge funds have recently modified their holdings of the stock. UMB Bank n.a. grew its holdings in shares of Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its position in shares of Acadia Healthcare by 11,218.2% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after acquiring an additional 1,234 shares during the period. Signaturefd LLC lifted its position in shares of Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after acquiring an additional 1,004 shares during the period. Quadrant Capital Group LLC lifted its position in shares of Acadia Healthcare by 287.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after acquiring an additional 933 shares during the period. Finally, State of Wyoming acquired a new stake in shares of Acadia Healthcare during the 4th quarter valued at approximately $56,000.
Acadia Healthcare Stock Performance
ACHC opened at $24.08 on Tuesday. The firm has a market capitalization of $2.22 billion, a PE ratio of 11.86, a PEG ratio of 4.64 and a beta of 0.93. Acadia Healthcare has a twelve month low of $20.36 and a twelve month high of $82.41. The firm's 50-day moving average price is $23.15 and its 200 day moving average price is $30.64. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. Acadia Healthcare's quarterly revenue was up .3% on a year-over-year basis. During the same period in the previous year, the business posted $0.84 earnings per share. As a group, sell-side analysts expect that Acadia Healthcare will post 3.38 EPS for the current fiscal year.
About Acadia Healthcare
(
Get Free ReportAcadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.